We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Thirty-Two Products Developed for Immunophenotyping of Hematologic Malignancies

By LabMedica International staff writers
Posted on 14 Apr 2011
Thirty-two new clinical flow cytometry reagents have been developed for immunophenotyping of hematologic malignancies.

A provider of reagents for multicolor flow cytometry has expanded its portfolio of antibodies, fluorochromes, and reagents for diagnostics, immunology, oncology, cell biology, and stem cell biology.

eBioscience (San Diego, CA, USA) manufactures the clinical reagents under The Good Manufacturing Practice (GMP) environment. More...
The company assures good signal to noise and more than 90% purity.

The Clinical Flow Cytometry Reagent product line was developed and optimized by eBioscience for the clinical laboratory user. The antibodies are packaged in flexible sizes to help manage precise budgets. All sizes are formulated at 5 µL/test to ensure efficient multicolor immunophenotyping by reducing the ratio of reagent solution to sample volume--critical for conserving precious samples. The wide selection of fluorochrome formats are needed for the variety of cytometers now found in clinical laboratories.

The American Association for Cancer Research (AACR) 102nd Annual Meeting, (April 2–6, 2011) in Orlando (FL, USA) and the XXVI Congress of the International Society for Advancement of Cytometry (CYTO2011), May 2011 in Baltimore, (MD, USA) are showcasing eBioscience's expanding portfolio of clinical reagents.

Related Links:
eBioscience


New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Integrated Biochemical & Immunological System
Biolumi CX8
New
Pan-Cancer Panel
TruSight Oncology 500
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.